Ron Stubbers, MBA
Ron Stubbers focuses on the company’s operations, product development, engineering, quality, and regulatory activities. Ron has more than 25 years of experience in operations, engineering, and management of quality and regulatory affairs, product development, and manufacturing engineering. Throughout his career, he has contributed to the development and expansion of companies through organic growth and M&A endeavors.
Fabian Alt, M.Sc.
Chief Financial Officer
Fabian Alt previously served in the Investment Banking Division of Goldman Sachs’s London office. His experience extends across more than 20 completed capital market and M&A transactions, including several equity capital offerings and IPOs. Fabian received his master’s in finance from the London School of Economics and Political Science, earned an honors master’s in technology management from the Technical University of Munich and Ludwig-Maximilians-University Munich, and received a master’s in physics from the Technical University of Munich. In addition, he completed research stays at the Max Planck Institute for Quantum Optics and Massachusetts Institute of Technology.
Glenn Winnier, PhD
Chief Scientific Officer
Glenn Winnier has more than 15 years of experience in scientific leadership and a proven track record in the design of studies that have led to the successful commercialization of novel therapeutics. Previously, he worked for Memorial Hermann, Houston Methodist Research Institute, Opexa Therapeutics, and Lexicon Genetics, where he gained experience in disciplines ranging from the development of intellectual property to regulatory affairs, cGMP manufacturing, and clinical trial management. Glenn received his doctorate in cell biology from Vanderbilt University.